Inhibition of human monoamine oxidase A and B by 5-phenoxy 8-aminoquinoline analogs
Authors:
- Narayan D. ChaurasiyaNCNarayan D. Chaurasiya
- Shobana GanesanSGShobana Ganesan
- N.P. Dhammika NanayakkaraNNN.P. Dhammika Nanayakkara
- Luiza R.S. DiasLDLuiza R.S. Dias
- Larry A. WalkerLWLarry A. Walker
- Babu L. TekwaniBTBabu L. Tekwani
- 1 February 2012
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 22 (4) , 1701-1704
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Monoamine oxidase inactivation: From pathophysiology to therapeuticsAdvanced Drug Delivery Reviews, 2008
- Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including humanToxicology, 2005
- Clinical Pharmacology of MAO Inhibitors: Safety and FutureNeuroToxicology, 2004
- Monoamine Oxidase B Induces ERK-Dependent Cell Mitogenesis by Hydrogen Peroxide GenerationBiochemical and Biophysical Research Communications, 2000
- Metabolism of primaquine by liver homogenate fractionsExperimental and Toxicologic Pathology, 1999
- MONOAMINE OXIDASE: From Genes to BehaviorAnnual Review of Neuroscience, 1999
- Monoamine Oxidase InhibitorsDrugs & Aging, 1998
- Interactions of the novel inhibitors of MAO B Ro 19-6327 and Ro 16-6491 with the active site of the enzymePharmacological Research Communications, 1988
- Some observations upon a new inhibitor of monoamine oxidase in brain tissueBiochemical Pharmacology, 1968
- Hypertensive Interactions Between Monoamine Oxidase Inhibitors and FoodstuffsThe British Journal of Psychiatry, 1967